- Home
- SIM vs PCVX Comparison
SIM vs PCVX Comparison
Compare SIM & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIM
- PCVX
- Stock Information
- Founded
- SIM 1969
- PCVX 2013
- Country
- SIM Mexico
- PCVX United States
- Employees
- SIM N/A
- PCVX N/A
- Industry
- SIM Steel/Iron Ore
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- SIM Industrials
- PCVX Health Care
- Exchange
- SIM Nasdaq
- PCVX Nasdaq
- Market Cap
- SIM 4.2B
- PCVX 4.4B
- IPO Year
- SIM 1993
- PCVX 2020
- Fundamental
- Price
- SIM $28.23
- PCVX $35.76
- Analyst Decision
- SIM
- PCVX Strong Buy
- Analyst Count
- SIM 0
- PCVX 10
- Target Price
- SIM N/A
- PCVX $136.50
- AVG Volume (30 Days)
- SIM 1.8K
- PCVX 1.5M
- Earning Date
- SIM 07-21-2025
- PCVX 08-05-2025
- Dividend Yield
- SIM N/A
- PCVX N/A
- EPS Growth
- SIM 122.92
- PCVX N/A
- EPS
- SIM 3.34
- PCVX N/A
- Revenue
- SIM $1,641,713,837.00
- PCVX N/A
- Revenue This Year
- SIM N/A
- PCVX N/A
- Revenue Next Year
- SIM N/A
- PCVX N/A
- P/E Ratio
- SIM $8.46
- PCVX N/A
- Revenue Growth
- SIM N/A
- PCVX N/A
- 52 Week Low
- SIM $22.15
- PCVX $27.66
- 52 Week High
- SIM $31.00
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- SIM 68.26
- PCVX 57.77
- Support Level
- SIM $27.94
- PCVX $31.79
- Resistance Level
- SIM $29.60
- PCVX $36.89
- Average True Range (ATR)
- SIM 0.23
- PCVX 1.51
- MACD
- SIM 0.16
- PCVX 0.37
- Stochastic Oscillator
- SIM 59.35
- PCVX 77.65
About SIM Grupo Simec S.A.B. de C.V.
Grupo Simec SAB de CV is a diversified producer, processor and distributor of SBQ steel and structural steel products with production and commercial operations. The group's SBQ products are used across a range of engineered end-user applications, including axles, hubs, and crankshafts for automobiles and light trucks, machine tools, and off-highway equipment. Its structural steel products are used in the non-residential construction market and other construction applications. Its segments are Mexico, Brazil, and the United States. The maximum of its sales is from the Mexico segment.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.